Insider · CIK 0002110286
Brigitte Ute Lindsay
Files at CRDF (Cardiff Oncology, Inc.). First filing -, latest -.
In brief
Brigitte Ute Lindsay files SEC Form 4 as officer at CRDF (Cardiff Oncology, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Brigitte Ute Lindsay has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | CRDF Cardiff Oncology, Inc. | AGrant or award Stock Optionsderivative | +200,000 | $0.00 | $0 | 1,025,334 | Feb 18, 2026 |
Questions about Brigitte Ute Lindsay
Answered from the filings on this page, as of the latest one.
Is Brigitte Ute Lindsay buying or selling?
Brigitte Ute Lindsay has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Brigitte Ute Lindsay's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brigitte Ute Lindsay has 0.
Where does Brigitte Ute Lindsay file Form 4?
Brigitte Ute Lindsay has filed Form 4 at CRDF (Cardiff Oncology, Inc.) as Chief Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.